Stronger together: The coupling up of the healthcare industry

Cara Livernois | | Health Exec | Economics

It seems that everyone is pairing up these days. From Abbott reaching a deal to buy St. Jude Medical for $25 billion, Sanofi making an offer to Medivation for $9.3 billion and AbbVie signing a deal with Stemcnetrx for $5.8 billion.

As a recent New York Times article explains, many in the industry are having the same idea: Pair up with your competitors to become a leading provider and gain power to negotiate business with hospitals and insurers.

Read more by following the link below:

Health Care Companies See Scale as the Only Way to Compete

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

American Heart Association highlights importance of NIH as battle over Trump funding cuts continues
Federal judge sides with FTC; case against PBMs to move forward
UnitedHealth pushes back against shareholder transparency proposal
Thousands of staff cut from federal health agencies, including CDC and VA
Nonprofit academic hospital receives criticism after running Super Bowl ad
HeartBeam raising $10M for FDA-cleared health tech with public offering

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”